Detalhe da pesquisa
1.
Community Risk Score for Evaluating Health Care Disparities in Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(4): 877-879, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29292058
2.
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1029-1034, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29369800
3.
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.
Blood Adv
; 7(16): 4505-4513, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352262
4.
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era.
Hematol Oncol Stem Cell Ther
; 14(4): 318-326, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301747
5.
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid Leukemia.
Clin Lymphoma Myeloma Leuk
; 21(2): 113-118, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33422470
6.
A methodology to establish a database to study gene environment interactions for childhood asthma.
BMC Med Res Methodol
; 10: 107, 2010 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21134251
7.
Psychosocial Assessment of Candidates for Transplant (PACT) as a tool for psychological and social evaluation of allogeneic hematopoietic cell transplantation recipients.
Bone Marrow Transplant
; 54(9): 1443-1452, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30696998
8.
Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Blood Adv
; 3(18): 2732-2737, 2019 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31530545
9.
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 54(5): 775-781, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30375493
10.
A retrospective analysis of longitudinal changes in bone mineral content in cystic fibrosis.
J Pediatr Endocrinol Metab
; 30(8): 807-814, 2017 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28222031
11.
Day 100 risk assessment tool predicts overall survival in allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 57(1): 131-133, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34628474
12.
Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant.
Bone Marrow Transplant
; 57(6): 1031-1033, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428866
13.
Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 19(7): e374-e376, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31053548
14.
Intravenous compared to oral busulfan with cyclophosphamide for autologous hematopoietic cell transplant conditioning for plasma cell myeloma.
Hematol Oncol Stem Cell Ther
; 11(4): 253-256, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29705567
15.
Models of paediatric care for cystic fibrosis: local clinics can deliver equitable care and offer many benefits.
Arch Dis Child
; 97(1): 88-9; author reply 89-90, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22167044